DIASORIN S.P.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 94.9 EUR | +1.32% |
|
+4.08% | +1.78% |
| 04-24 | Citadel Advisors initiates short on STMicroelectronics. | AN |
| 04-23 | Reduced a short on DiaSorin, increased on STM. | AN |
Business Summary
At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.
Number of employees: 3,209
Sales per Business
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Diagnostic Kits
100.0
%
| 1,361 | 100.0 % | 1,148 | 100.0 % | -15.64% |
Sales per region
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
North America
52.9
%
| 783 | 57.5 % | 607 | 52.9 % | -22.41% |
Europe
23.1
%
| 269 | 19.8 % | 265 | 23.1 % | -1.53% |
Italy
15.1
%
| 198 | 14.5 % | 174 | 15.1 % | -12.14% |
Rest of the World
8.9
%
| 112 | 8.2 % | 102 | 8.9 % | -8.48% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Carlo Rosa
CEO | Chief Executive Officer | 58 | 31/12/97 |
| Director of Finance/CFO | 53 | 31/12/10 | |
| Director/Board Member | 61 | 31/12/99 | |
Riccardo Fava
IRC | Investor Relations Contact | - | - |
Stefano Ronchi
HRO | Human Resources Officer | 64 | 31/12/06 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 28/04/22 | |
Michele Denegri
CHM | Chairman | 55 | 25/03/07 |
Carlo Rosa
CEO | Chief Executive Officer | 58 | 31/12/97 |
| Director/Board Member | 61 | 31/12/99 | |
| Director/Board Member | 84 | 27/04/16 | |
Luca Melindo
BRD | Director/Board Member | 53 | 23/04/19 |
Monica Tardivo
BRD | Director/Board Member | 54 | 27/04/16 |
Tullia Todros
BRD | Director/Board Member | 75 | 31/12/15 |
Fiorella Altruda
BRD | Director/Board Member | 71 | 27/04/16 |
| Director/Board Member | 54 | 28/04/22 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 55,948,257 | 21,096,460 ( 37.71 %) | 2,588,278 ( 4.626 %) | 37.71 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
DIASORIN S.P.A. 4.86% | 2,716,663 | 4.86% | 262,592,646 $ |
IMPEDIMED LIMITED 0.66% | 13,300,000 | 0.66% | 798,266 $ |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
Luminex Molecular Diagnostics, Inc.
 Luminex Molecular Diagnostics, Inc. Medical/Nursing ServicesHealth Services Luminex Molecular Diagnostics, Inc. develops DNA based diagnostics tests and software solutions, which include genetic tests for disorders, drug metabolism and infectious diseases. The firm’s products include P450-2D6, P450-2C9, P450-2C19, AJ panel and CFTR. The company was founded in March 2007 and is headquartered in Toronto, Canada. |
Medical/Nursing Services
|
Diasorin, Inc.
 Diasorin, Inc. Medical SpecialtiesHealth Technology Diasorin, Inc. develops and manufactures reagents for in vitro diagnostics. It has products in the fields of infectious disease, hepatitis, endocrinology, bone and mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The company was founded in 1975 and is headquartered in Stillwater, MN. |
Medical Specialties
|
Diasorin Italia SpA
 Diasorin Italia SpA Medical/Nursing ServicesHealth Services Part of DiaSorin SpA, Diasorin Italia SpA is a diagnostic specialist that develops, produces, and globally markets reagent kits for in vitro diagnostics. Diasorin Italia is based in Saluggia, Italy. The Italian company continues to invest in research and development, leveraging its expertise in immunodiagnostics to deliver high-quality assays and improve laboratory efficiency. Ugo Gay has been the CEO of the private company since 2000. |
Medical/Nursing Services
|
Sector
Sales per region
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +1.78% | 5.41B | |
| +0.89% | 12.8B | |
| -10.29% | 7.61B | |
| -1.16% | 4.51B | |
| +5.74% | 4.49B | |
| -50.70% | 3.3B | |
| +12.21% | 2.73B | |
| -16.13% | 2.02B | |
| -11.50% | 1.73B | |
| -5.02% | 1.64B |
- Stock Market
- Equities
- DIA Stock
- Company DiaSorin S.p.A.
